Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Avant-garde Health
company
About
Avant-garde Health is a provider of health care services.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $12M
- Industries
- Health Care,Home Health Care,Hospital
- Founded date
- Jan 1, 2014
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Avant-garde Health partners with leading health care providers committed to improving the value of care. Avant-garde's software solutions generate actionable insights that enable health care providers to understand and improve their costs and outcomes across the care continuum.Avant-garde Health was born out of the Harvard Business School’s value-based health care delivery research, led by Professors Michael Porter and Robert Kaplan. Our growing team is backed by a group of leading investors, and we are dedicated to transforming health care delivery for decades to come.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$16M
Avant-garde Health has raised a total of
$16M
in funding over 2 rounds. Their latest funding was raised on
Mar 10, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 10, 2022 | Series A | $12M | 1 | — | — | Detail |
| Jan 8, 2018 | Seed | $4M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Avant-garde Health is funded by 1 investors.
General Catalyst
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
General Catalyst
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
